定制化出生体重百分位与胎盘相关胎儿生长受限
本研究为前瞻性队列二次分析,纳入857名低危初产妇,比较定制化与人群出生体重曲线诊断小于胎龄儿(SGA)对异常胎盘病理的预测准确性。结果显示定制化SGA与任何胎盘病理、母体血管灌注不良、慢性绒毛炎及胎儿血管灌注不良风险增加相关,且检出率更高。
要点
- 定制化SGA与任何胎盘病理风险增加相关(aRR 3.04,95%CI 2.29-4.04)。
- 定制化SGA与母体血管灌注不良风险显著增加相关(aRR 12.33,95%CI 6.60-23.03)。
- 定制化SGA对任何胎盘病理检出率高于人群SGA(30.3% vs 17.1%,P<0.001)。
核心结论
- 定制化出生体重百分位可能优于人群百分位,用于检测由潜在胎盘疾病导致的胎儿生长受限。
研究设计与样本
- 前瞻性队列研究的二次分析,纳入857名低危初产妇,所有胎盘由两位围产病理学家进行详细组织病理学检查。
主要发现
- 定制化SGA和人群SGA比例分别为12.6%(108/857)和11.4%(98/857)。
- 定制化SGA与任何胎盘病理(aRR 3.04,95%CI 2.29-4.04)和MVM病理(aRR 12.33,95%CI 6.60-23.03)风险增加相关。
- 人群SGA与任何胎盘病理(aRR 1.60,95%CI 1.10-2.31)和MVM病理(aRR 5.29,95%CI 2.87-9.76)风险增加相关。
- 定制化SGA还与慢性绒毛炎(aRR 1.85,95%CI 1.07-3.18)和FVM病理(aRR 2.48,95%CI 1.25-4.93)风险增加相关,而人群SGA无此关联。
- 在相似假阳性率下,定制化SGA对任何胎盘病理(30.3% vs 17.1%;P<0.001)、MVM病理(63.2% vs 39.5%;P=0.003)和慢性绒毛炎(20.8% vs 8.3%;P=0.007)的检出率高于人群SGA。
关键数值与推荐
- SGA定义为出生体重低于同胎龄第10百分位,分别使用定制化(SGAcust)和人群(SGApop)出生体重参考。
- 调整相对风险(aRR)使用改良Poisson回归分析,调整吸烟、体重指数和阿司匹林治疗。
临床怎么用
- 临床中可考虑使用定制化出生体重百分位来识别可能由胎盘疾病导致的胎儿生长受限,以提高诊断准确性。
局限性
- 本研究为二次分析,原始队列为低危初产妇,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The value of using customized birth-weight centiles to improve the diagnostic accuracy for fetal growth restriction (FGR), in comparison with using population-based charts, remains a matter of debate. One potential explanation for the conflicting data is that most studies used measures of perinatal mortality and morbidity as proxies for placenta-mediated FGR, many of which are not specific and may be confounded by other factors such as prematurity. The aim of this study was to compare the diagnostic accuracy of small-for-gestational age (SGA) at birth, defined according to customized vs population-based charts, for associated abnormal placental pathology. METHODS: This was a secondary analysis of data from a prospective cohort study on risk factors for placenta-mediated complications and abnormal placental pathology in low-risk nulliparous women. All placentae were sent for detailed histopathological examination by two perinatal pathologists. The primary exposure was SGA, defined as birth weight < 10th centile for gestational age using either a customized (SGAcust ) or a population-based (SGApop ) birth-weight reference. The outcomes of interest were one of three types of abnormal placental pathology associated with FGR: maternal vascular malperfusion (MVM), chronic villitis and fetal vascular malperfusion (FVM). Adjusted relative risks (aRR) with 95% CIs were estimated using modified Poisson regression analysis, with adjustment for smoking, body mass index and aspirin treatment. RESULTS: A total of 857 nulliparous women met the study criteria. The proportions of infants identified as SGA based on the customized and population-based charts were 12.6% (108/857) and 11.4% (98/857), respectively. A diagnosis of SGA using either customized or population-based charts was associated with an increased risk of any placental pathology (aRR, 3.04 (95% CI, 2.29-4.04) and 1.60 (95% CI, 1.10-2.31), respectively) and MVM pathology (aRR, 12.33 (95% CI, 6.60-23.03) and 5.29 (95% CI, 2.87-9.76), respectively). SGAcust , but not SGApop , was also associated with an increased risk for chronic villitis (aRR, 1.85 (95% CI, 1.07-3.18)) and FVM pathology (aRR, 2.48 (95% CI, 1.25-4.93)). SGAcust had a higher detection rate for any placental pathology (30.3% vs 17.1%; P < 0.001), MVM pathology (63.2% vs 39.5%; P = 0.003) and chronic villitis (20.8% vs 8.3%; P = 0.007) than did SGApop , for a similar false-positive rate. This was mainly the result of a higher detection rate for abnormal pathology in the white and East-Asian subgroups and a lower false-positive rate for abnormal pathology in the South-Asian subgroup by SGAcust than by SGApop . In addition, pregnancies in the SGAcust group, but not those in the SGApop group, were more likely to be complicated by preterm birth and a low 5-min Apgar score than were the corresponding non-SGA group. CONCLUSION: These findings suggest that customized birth-weight centiles may be superior to population-based birth-weight centiles in detecting FGR that is due to underlying placental disease. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Melamed N, Hiersch L, Aviram A, et al. Customized birth-weight centiles and placenta-related fetal growth restriction. Ultrasound Obstet Gynecol. 2021. PMID: 33073889. doi:10.1002/uog.23516
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。